Around a quarter of people in low-income areas could benefit from GLP-1 weight-loss drugs, but costs of $1,000-$1,400 make it unaffordable, even for some wealthier patients.
Disparities in access to weight-loss medications deepen in low-income states like West Virginia, where insurance limitations and high costs limit coverage, leaving many unable to afford necessary treatments.
#healthcare-costs #insurance-coverage #health-disparities #weight-loss-medications #public-health-initiatives
[
Collection
]
[
|
...
]